A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations

Clinical trial NCT07746141 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07746141
Sponsor: BeOne Medicines
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

RAS Mutation Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2026-09-04
Primary completion: 2028-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.